Danial, Abdurahman H.
HRN: 21-29-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/03/2022
05/09/2022
IV
1.5 G
Q6H
Furunculosis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes